HAP1 and rheumatoid arthritis: In this study [78], the liposomal formulation with p-coumaric acid and HAP-1 peptide demonstrated the highest therapeutic effectiveness in RA since it enabled a dose-reduction combined with significant and long-term suppression of the inflammation in arthritic rats.